Page not found

Search results

  1. Vanderbilt-Ancora partnership advances research for rare form of epilepsy 

    ... are resistant to most current epilepsy treatments. Thus, new therapeutic approaches are desperately needed.  The goal of the latest ... compound. The work, in conjunction with the  Center for Technology Transfer and Commercialization , will continue to be led by  C. ...

    sommers - 10/31/2022 - 12:18pm

  2. Center for Technology Transfer and Commercialization breaks records in leveraging innovation and discovery at Vanderbilt

    ... 10/10/2022 The  Vanderbilt Center for Technology Transfer and Commercialization  generated more than $100 million ... for patients with asymptomatic severe aortic stenosis, treatment of sleep apnea through nerve stimulation, an MRI study to ...

    sommers - 10/10/2022 - 10:35am

  3. Vanderbilt inks collaboration with Neumora Therapeutics, Inc to continue development of investigational treatment for neuropsychiatric disorders

    ... plans to develop the M4 receptor modulator program for the treatment of schizophrenia through the development of Data Biopsy Signatures™ ... Thomas Utley, senior licensing officer at the  Center for Technology Transfer and Commercialization . “The team that Neumora has put ...

    sommers - 05/06/2022 - 10:50am

  4. Taking a bite out of Charcot-Marie-Tooth Disease

    ... manager of corporate alliances for Vanderbilt’s Center for Technology Transfer and Commercialization,  attended a global conference ...

    sommers - 03/18/2024 - 1:36pm

  5. Novel anti-platelet therapy for treatment of thrombosis, cardiovascular disease, and cerebrovascular injury

    Technology Description Cardiovascular disease remains one of the ... thromboembolism and, as such, are desirable targets for the treatment of thrombosis. Vanderbilt researchers have recently developed novel ... benefits for patients that minimize severe bleeding during treatment for thrombotic events. Commercial Applications ...

    cttc_admin - 01/23/2024 - 1:42pm

  6. Prothena and Warren Center for Neuroscience Drug Discovery collaborate on new Alzheimer’s disease therapeutics

    ... agreement to develop new small molecule therapeutics for the treatment of Alzheimer’s disease in individuals with Down syndrome.   ... Thomas Utley, senior licensing officer at the  Center for Technology Transfer and Commercialization . “The relationship among all ...

    sommers - 05/09/2022 - 9:10am

  7. ThermoFisher Scientific - Research Interest Areas

    ... analysis of recombinant protein quality; rapid bioburden technology; bioprocess data analytics; technologies for new biotherapeutic ... resin/plastic/polymer; injection blow molding; surface treatment processes to block migration from plastic to sample; refrigeration; ...

    cttc_admin - 01/30/2024 - 12:26pm

  8. Ono Extends Drug Discovery Collaboration Agreement with Vanderbilt University

    ... University (Tennessee, USA) to discover novel, efficacious therapeutic drugs for diseases with unmet medical needs. Under the ... on the validation, will discover clinical candidates for the treatment of CNS disorders. Taking into the favorable performance in the ...

    sommers - 01/04/2022 - 9:22am

  9. Faculty can quickly and easily share their innovative ideas using CTTC’s new online tool

    02/15/2024 The Center for Technology Transfer and Commercialization has introduced a new tool that makes ...

    sommers - 02/15/2024 - 1:35pm

  10. Soldier-inspired innovation incubator team wins $500K first-place prize at xTechBOLT Competition

    ... and Development Command’s  xTechBrain Operant Learning Technology (xTechBOLT) prize competition , which seeks to promote high-risk, ... where soldiers may need to administer life-saving treatment with no time to spare. That latter aspect of recalling training ...

    sommers - 01/24/2022 - 9:17am